Side effects of antipsychotic drugs: Avoiding and minimizing their impact in elderly patients

Postgraduate Medicine

Volumn 107, Issue 2, 2000, Pages 169-178

  Saltz, Bruce L ^a   Woerner, Margaret G ^a   Robinson, Delbert G ^a   Kane, John M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; HYPNOTIC SEDATIVE AGENT; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE; ZIPRASIDONE;

AGITATION; AGRANULOCYTOSIS; AKATHISIA; ARTICLE; CREATINE KINASE BLOOD LEVEL; DEHYDRATION; DIAPHORESIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG FORMULATION; DRUG POTENCY; DRUG WITHDRAWAL; DYSTONIA; ELDERLY CARE; HUMAN; HYPERTHERMIA; MUSCLE RIGIDITY; PARKINSONISM; PSYCHOSIS; TARDIVE DYSKINESIA;

EID: 0033951248     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2000.02.891     Document Type: Article

References (14)

1. Harrington C, Tompkins C, Curtis M, et al. Psychotropic drug use in long-term care facilities: a review of the literature. Gerontologist 1992;32(6):822-33
2. Salzman C. Treatment of agitation in the elderly. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987:1167
3. Kane JM, Woerner MG, Pollack S, et al. Does clozapine cause tardive dyskinesia? J Clin Psychiatry 1993;54(Sep):327-30
4. Saltz BL, Woerner MG, Lieberman JA, et al. Development of drug-induced parkinsonism in elderly individuals receiving neuroleptics for the first time. International Congress on Schizophrenia Research. Tuscon, Arizona: 1990 Apr
5. Barnes TR. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia. Psychiatric Developments 1987:4:301-19
6. Burke RE, Fahn S, Marsden CD, et al. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985;35:73-7
7. Delwaide PJ, Desseilles M. Spontaneous huccolinguofacial dyskinesia in the elderly. Acta Neurol Scand 1977;56(3):256-62
8. Brandon S, McClelland HA, Protheroe C. A study of facial dyskinesia in a mental hospital population. Br J Psychiatry 1971; 118:171-84
9. Woerner MG, Alvir JM, Saltz BL, et al. Prospective study of tardive dyskinesia in the elderly: rates and risk factors. Am J Psychiatry 1998;155(11):1521-8
10. Jeste DV, Caligiuri MP, Paulsen JS, et al. Risk of tardive dyskinesia in older patients: a prospective longitudinal study of 266 outpatients. Arch Gen Psychiatry 1995;52(Sep):756-65
11. Mental Health Advocates. Recognizing and managing antipsychotic drug side effects (a videotape-based educational program). Boca Raton, Florida: Mental Health Advocates Inc, 1998
12. Adler L, Angrist B, Peselow E, et al. Noradrenergic mechanisms in akathisia: treatment with propranolol and clonidine. Psychopharmacol Bull 1987;23(1):21-5
13. Nishikawa T, Tanaka M, Tsuda A, et al. Clonidine therapy for tardive dyskinesia and related syndromes. Clin Neuropharmacol 1984;7(3):239-45
14. Tollefson GD, Beasley CM Jr, Tamura RN, et al. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. Am J Psychiatry 1997; 154(Sep):1248-54